Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kelch-like protein 28 (KLHL28) is a soluble, cytoplasmic adaptor protein encoded by the KLHL28 gene. It belongs to the larger kelch-like protein family, characterized by a conserved set of motifs: BTB/POZ domain (protein binding/dimerization), a BACK domain (putative structural importance), and multiple kelch domains forming a β-propeller fold[1][3]. KLHL28 is broadly expressed, with elevated levels in brain and heart tissue, and interacts with numerous proteins forming part of the E3 ubiquitin ligase complex—most prominently Cullin-3 (CUL3)[1]. This complex is critical for protein turnover via ubiquitin-mediated degradation. KLHL28 dysregulation has been linked in genomic studies to increased risk of cancer, hypertension, and epilepsy[1][2][3]. Unlike classical receptors or enzymes targeted by drugs, KLHL28 serves mostly as a substrate adaptor within protein degradation pathways. Its clinical significance is largely based on its genetic, molecular, or functional involvement in disease states rather than as a direct therapeutic target[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kelch-like protein 28 (KLHL28).